Nu-Med Plus (NUMD) Share-based Compensation (2012 - 2022)
Nu-Med Plus (NUMD) reported Share-based Compensation of $35000.0 for Q3 2022, up 106.68% sequentially from -$524314.0 in Q4 2021.
Nu-Med Plus (NUMD) Share-based Compensation (2012 - 2022) Analysis & Trends
Nu-Med Plus (NUMD) has 11 years of Share-based Compensation data on file, last reported at $35000.0 in Q3 2022.
- For the quarter ending Q3 2022, Share-based Compensation changed N/A year-over-year to $35000.0; the trailing twelve-month figure through Dec 2022 stood at -$489314.0 (down 344.66% YoY), and the FY2023 full-year result was $41800.0, up 19.43% from the prior year.
- Share-based Compensation climbed to $35000.0 in Q3 2022, from -$524314.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $724314.0 in Q1 2021 to a low of -$664777.0 in Q4 2020.
- A 5-year average of $61223.7 and a median of $50000.0 in 2018 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 2461.22% in 2018 and plunged 3512.26% in 2020, its largest moves.
- Tracing NUMD's Share-based Compensation over 5 years: stood at -$309000.0 in 2018, then jumped by 106.3% to $19482.0 in 2019, then sank by 3512.26% to -$664777.0 in 2020, then rose by 21.13% to -$524314.0 in 2021, then jumped by 106.68% to $35000.0 in 2022.
- Business Quant data shows NUMD's Share-based Compensation at $35000.0 in Q3 2022, -$524314.0 in Q4 2021, and $724314.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Dec 31, 2021 | -524,314.00 |
| Dec 31, 2021 | -524,314.00 |
| Mar 31, 2021 | 724,314.00 |
| Mar 31, 2021 | 724,314.00 |
| Dec 31, 2020 | -664,777.00 |
| Dec 31, 2020 | -664,777.00 |
| Sep 30, 2020 | 87,500.00 |
| Sep 30, 2020 | 87,500.00 |
| Jun 30, 2020 | 611,150.00 |
| Jun 30, 2020 | 611,150.00 |
| Mar 31, 2020 | 50,000.00 |
| Mar 31, 2020 | 50,000.00 |
| Dec 31, 2019 | 19,482.00 |
| Dec 31, 2019 | 19,482.00 |
| Sep 30, 2019 | 50,000.00 |
| Sep 30, 2019 | 50,000.00 |
| Jun 30, 2019 | 50,000.00 |
| Jun 30, 2019 | 50,000.00 |